Skip to main content
. 2018 Nov 27;11:8381–8388. doi: 10.2147/OTT.S181314

Figure 4.

Figure 4

The prognostic value of PRDX4 expression in the database.

Notes: The valid Affymetrix ID is 201923_at (PRDX4). Survival curves are plotted for (A) all patients (n=1,926), HR=0.95 (95% CI: 0.87–1.12); (B) adenocarcinoma (n=720), HR=0.93 (95% CI: 0.73–1.17); (C) squamous cell carcinoma (n=524), HR=0.79 (95% CI: 0.62–1.01).